Control of topiramate-induced paresthesias with supplemental potassium.
Silberstein
Stephen D
SD
D000927:Anticonvulsants / Q000009:adverse effects*; D005632:Fructose / Q000009:adverse effects* / Q000031:analogs & derivatives; D006801:Humans; D010292:Paresthesia / Q000139:chemically induced* / Q000188:drug therapy*; D011188:Potassium / Q000627:therapeutic use*; D000077236:Topiramate
D000927:Anticonvulsants; D000077236:Topiramate; D005632:Fructose; D011188:Potassium